Ozempic-maker sues rival, accusing it of false advertising

Novo Nordisk, the maker of Wegovy and Ozempic, has launched legal action accusing its arch rival Eli Lilly of false advertising.

SUBSCRIBE TO RIVIERA READY

Travel, fashion, culture and Riviera-inspired living — delivered straight to your inbox.

By subscribing, you agree to receive Riviera Ready Magazine emails. You can unsubscribe at any time. Please read our Privacy Policy. This newsletter is intended for readers aged 16 or over.